• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吸烟、己酸17α-羟孕酮与早产

Smoking, 17 Alpha-Hydroxyprogesterone Caproate, and Preterm Birth.

作者信息

Heyborne Kent D, Allshouse Amanda A

机构信息

Department of Obstetrics and Gynecology, Denver Health, Denver, Colorado.

Department of Biostatistics and Informatics, Colorado School of Public Health, Aurora, Colorado.

出版信息

Am J Perinatol. 2016 Oct;33(12):1191-7. doi: 10.1055/s-0036-1586119. Epub 2016 Jul 27.

DOI:10.1055/s-0036-1586119
PMID:27464018
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5737832/
Abstract

Objective The objective of this study was to determine if maternal smoking modifies the effectiveness of 17 α-hydroxyprogesterone caproate (17OHP-C). Study Design Secondary analysis of the Maternal-Fetal Medicine Units Network trial of 17OHP-C. The prevalence of preterm birth (PTB) by smoking status and treatment group was compared by chi-squared analysis and analysis of variance was used to compare gestational age (GA) at birth. Multivariable modeling was used to estimate the effect of smoking on 17OHP-C treatment. Results In this study, 459 women were included. Maternal smoking significantly modified the effectiveness of 17OHP-C treatment. In smokers, 17OHP-C significantly reduced the prevalence of multiple outcomes (PTB < 37 and < 35 weeks, spontaneous PTB < 37 and < 35 weeks), while in nonsmokers, only PTB < 37 weeks was reduced. Delivery GA was later in 17OHP-C versus placebo treated smokers (36.4 vs. 34.3 weeks, p = 0.041) but not nonsmokers (36.3 vs. 35.5 weeks, p = nonsignificant). In multivariable modeling, 17OHP-C was more effective in smokers than nonsmokers as measured by multiple outcomes (PTB < 37 weeks [p = 0.041] and < 35 weeks [p = 0.036] and spontaneous PTB < 37 weeks [p = 0.029]). Conclusion In this cohort of women with a prior PTB, maternal smoking status significantly modified the effectiveness of 17OHP-C treatment.

摘要

目的 本研究的目的是确定母亲吸烟是否会改变己酸17α-羟孕酮(17OHP-C)的疗效。研究设计 对17OHP-C的母胎医学单位网络试验进行二次分析。通过卡方分析比较不同吸烟状态和治疗组的早产(PTB)患病率,并使用方差分析比较出生时的孕周(GA)。采用多变量建模来估计吸烟对17OHP-C治疗的影响。结果 在本研究中,纳入了459名女性。母亲吸烟显著改变了17OHP-C治疗的疗效。在吸烟者中,17OHP-C显著降低了多种结局的患病率(PTB<37周和<35周、自发性PTB<37周和<35周),而在不吸烟者中,仅PTB<37周有所降低。与安慰剂治疗的吸烟者相比,17OHP-C治疗的吸烟者分娩孕周更晚(36.4对34.3周,p=0.041),但不吸烟者无此差异(36.3对35.5周,p=无显著性)。在多变量建模中,从多种结局衡量(PTB<37周[p=0.041]、<35周[p=0.036]和自发性PTB<37周[p=0.029]),17OHP-C对吸烟者比对不吸烟者更有效。结论 在这个有既往PTB史的女性队列中,母亲吸烟状态显著改变了17OHP-C治疗的疗效。

相似文献

1
Smoking, 17 Alpha-Hydroxyprogesterone Caproate, and Preterm Birth.吸烟、己酸17α-羟孕酮与早产
Am J Perinatol. 2016 Oct;33(12):1191-7. doi: 10.1055/s-0036-1586119. Epub 2016 Jul 27.
2
Does 17-alpha hydroxyprogesterone caproate prevent recurrent preterm birth in obese women?己酸17-α羟孕酮能否预防肥胖女性复发性早产?
Am J Obstet Gynecol. 2015 Dec;213(6):844.e1-6. doi: 10.1016/j.ajog.2015.08.014. Epub 2015 Aug 12.
3
Relation of body mass index to frequency of recurrent preterm birth in women treated with 17-alpha hydroxyprogesterone caproate.己酸17-α羟孕酮治疗的女性中体重指数与复发性早产频率的关系。
Am J Obstet Gynecol. 2015 Aug;213(2):233.e1-5. doi: 10.1016/j.ajog.2015.04.018. Epub 2015 Apr 23.
4
17 alpha-hydroxyprogesterone caproate does not prolong pregnancy or reduce the rate of preterm birth in women at high risk for preterm delivery and a short cervix: a randomized controlled trial.己酸17α-羟孕酮不会延长早产风险高且宫颈短的女性的孕期或降低早产率:一项随机对照试验。
Am J Obstet Gynecol. 2015 Apr;212(4):485.e1-485.e10. doi: 10.1016/j.ajog.2014.10.1097. Epub 2014 Oct 30.
5
17-hydroxyprogesterone caproate for preterm rupture of the membranes: a multicenter, randomized, double-blind, placebo-controlled trial.己酸17-羟孕酮用于胎膜早破:一项多中心、随机、双盲、安慰剂对照试验
Am J Obstet Gynecol. 2015 Sep;213(3):364.e1-12. doi: 10.1016/j.ajog.2015.05.009. Epub 2015 May 13.
6
Patient characteristics associated with 17-alpha hydroxyprogesterone caproate use among a high-risk cohort.高危队列中与己酸17-α羟孕酮使用相关的患者特征。
Am J Obstet Gynecol. 2016 Apr;214(4):536.e1-536.e5. doi: 10.1016/j.ajog.2015.10.148. Epub 2015 Oct 28.
7
The effect of 17α-hydroxyprogesterone caproate on preterm birth in women with an ultrasound-indicated cerclage.超声提示宫颈环扎术孕妇应用 17α-羟孕酮治疗早产的效果。
Am J Perinatol. 2011 May;28(5):389-94. doi: 10.1055/s-0031-1272967. Epub 2011 Mar 4.
8
Racial and ethnic disparities in use of 17-alpha hydroxyprogesterone caproate for prevention of preterm birth.种族和民族差异在使用 17-α 羟孕酮己酸酯预防早产中的应用。
Am J Obstet Gynecol. 2016 Mar;214(3):374.e1-6. doi: 10.1016/j.ajog.2015.12.054. Epub 2016 Jan 29.
9
Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth.己酸17-α羟孕酮预防复发性自发性早产疗效的预测因素
Am J Obstet Gynecol. 2016 Mar;214(3):376.e1-8. doi: 10.1016/j.ajog.2015.12.010. Epub 2015 Dec 12.
10
The effect of omega-3 supplementation on pregnancy outcomes by smoking status.ω-3补充剂对不同吸烟状况下妊娠结局的影响。
Am J Obstet Gynecol. 2017 Oct;217(4):476.e1-476.e6. doi: 10.1016/j.ajog.2017.05.033. Epub 2017 May 23.

本文引用的文献

1
17 Alpha-hydroxyprogesterone caproate for preterm prevention: issues in subgroup analysis.己酸17α-羟孕酮用于预防早产:亚组分析中的问题。
Am J Obstet Gynecol. 2016 Mar;214(3):306-7. doi: 10.1016/j.ajog.2015.12.002.
2
Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth.己酸17-α羟孕酮预防复发性自发性早产疗效的预测因素
Am J Obstet Gynecol. 2016 Mar;214(3):376.e1-8. doi: 10.1016/j.ajog.2015.12.010. Epub 2015 Dec 12.
3
Efficacy of midtrimester short cervix interventions is conditional on intraamniotic inflammation.
中期短宫颈干预的疗效取决于羊膜内炎症。
Am J Obstet Gynecol. 2016 Feb;214(2):276.e1-276.e6. doi: 10.1016/j.ajog.2015.09.006. Epub 2015 Sep 11.
4
Does 17-alpha hydroxyprogesterone caproate prevent recurrent preterm birth in obese women?己酸17-α羟孕酮能否预防肥胖女性复发性早产?
Am J Obstet Gynecol. 2015 Dec;213(6):844.e1-6. doi: 10.1016/j.ajog.2015.08.014. Epub 2015 Aug 12.
5
Pharmacogenomics of 17-alpha hydroxyprogesterone caproate for recurrent preterm birth prevention.17-α羟孕酮己酸酯预防复发性早产的药物基因组学研究。
Am J Obstet Gynecol. 2014 Apr;210(4):321.e1-321.e21. doi: 10.1016/j.ajog.2014.01.013. Epub 2014 Mar 1.
6
Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis.吸烟与心血管疾病:内皮功能障碍与早期动脉粥样硬化形成的机制。
Arterioscler Thromb Vasc Biol. 2014 Mar;34(3):509-15. doi: 10.1161/ATVBAHA.113.300156.
7
Trends in smoking before, during, and after pregnancy--Pregnancy Risk Assessment Monitoring System, United States, 40 sites, 2000-2010.妊娠前后吸烟趋势——妊娠风险评估监测系统,美国 40 个监测点,2000-2010 年。
MMWR Surveill Summ. 2013 Nov 8;62(6):1-19.
8
Relationship between 17-alpha hydroxyprogesterone caproate concentration and spontaneous preterm birth.17α-羟孕酮己酸酯浓度与自发性早产的关系。
Am J Obstet Gynecol. 2014 Feb;210(2):128.e1-6. doi: 10.1016/j.ajog.2013.10.008. Epub 2013 Oct 7.
9
Practice bulletin no. 130: prediction and prevention of preterm birth.第130号实践公告:早产的预测与预防
Obstet Gynecol. 2012 Oct;120(4):964-73. doi: 10.1097/AOG.0b013e3182723b1b.
10
Progesterone and preterm birth prevention: translating clinical trials data into clinical practice.孕酮与早产预防:将临床试验数据转化为临床实践。
Am J Obstet Gynecol. 2012 May;206(5):376-86. doi: 10.1016/j.ajog.2012.03.010.